HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johannes Rheinlaender Selected Research

Johannes Rheinlaender Research Topics

Disease

4Thrombosis (Thrombus)
10/2018 - 12/2015
3Coronary Artery Disease (Coronary Atherosclerosis)
05/2022 - 07/2017
2Inflammation (Inflammations)
10/2018 - 12/2015
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2022
1Thrombocytopenia (Thrombopenia)
01/2022
1Thromboinflammation
01/2022
1Neoplasms (Cancer)
04/2021
1Cardiovascular Diseases (Cardiovascular Disease)
10/2018
1Myocardial Infarction
10/2018
1Acute Coronary Syndrome
07/2017
1Carotid Artery Injuries
07/2017
1Wounds and Injuries (Trauma)
12/2015
1Hemorrhagic Shock
12/2015
1Endocarditis
05/2014
1Keratoconus
01/2014
1Neuroacanthocytosis
01/2013
1Necrosis
01/2013

Drug/Important Bio-Agent (IBA)

2LipidsIBA
01/2022 - 07/2017
2Proteins (Proteins, Gene)FDA Link
05/2014 - 01/2013
1Junctional Adhesion Molecule AIBA
05/2022
1Heparin (Liquaemin)FDA LinkGeneric
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Glycoproteins (Glycoprotein)IBA
10/2018
1AnaphylatoxinsIBA
10/2018
1Complement System Proteins (Complement)IBA
10/2018
1CXCR ReceptorsIBA
07/2017
1Chemokine CXCL12IBA
07/2017
1oxidized low density lipoproteinIBA
07/2017
1ferric chlorideIBA
07/2017
1ThrombinFDA Link
01/2017
1HMGB1 Protein (HMG1)IBA
12/2015
1QuartzIBA
05/2014
1Riboflavin (Vitamin B2)FDA LinkGeneric
01/2014
1Caspase 3 (Caspase-3)IBA
01/2013

Therapy/Procedure

1Traction
04/2021
1Corneal Cross-Linking
01/2014